Ecosystem CO2 release driven by wind occurs in drylands at global scale.

Subterranean ventilation is a non-diffusive transport process that provokes the abrupt transfer of CO2 -rich air (previously stored) through water-free soil pores and cracks from the vadose zone to the atmosphere, under high-turbulence conditions. In dryland ecosystems, whose biological carbon exchanges are poorly characterized, it can strongly determine eddy-covariance CO2 fluxes that are used to validate remote sensing products and constrain models of gross primary productivity. Although subterranean ventilation episodes (VE) may occur in arid and semi-arid regions, which are unsung players in the global carbon cycle, little research has focused on the role of VE CO2 emissions in land-atmosphere CO2 exchange. This study shows clear empirical evidence of globally occurring VE. To identify VE, we used in situ quality-controlled eddy-covariance open data of carbon fluxes and ancillary variables from 145 sites in different open land covers (grassland, cropland, shrubland, savanna, and barren) across the globe. We selected the analyzed database from the FLUXNET2015, AmeriFlux, OzFlux, and AsiaFlux networks. To standardize the analysis, we designed an algorithm to detect CO2 emissions produced by VE at all sites considered in this study. Its main requirement is the presence of considerable and non-spurious correlation between the friction velocity (i.e., turbulence) and CO2 emissions. Of the sites analyzed, 34% exhibited the occurrence of VE. This vented CO2 emerged mainly from arid ecosystems (84%) and sites with hot and dry periods. Despite some limitations in data availability, this research demonstrates that VE-driven CO2 emissions occur globally. Future research should seek a better understanding of its drivers and the improvement of partitioning models, to reduce uncertainties in estimated biological CO2 exchanges and infer their contribution to the global net ecosystem carbon balance.

Magnetic properties of nanoparticles as a function of their spatial distribution on liposomes and cells.

The aggregation processes of magnetic nanoparticles in biosystems are analysed by comparing the magnetic properties of three systems with different spatial distributions of the nanoparticles. The first one is iron oxide nanoparticles (NPs) of 14 nm synthesized by coprecipitation with two coatings, (3-aminopropyl)trimethoxysilane (APS) and dimercaptosuccinic acid (DMSA). The second one is liposomes with encapsulated nanoparticles, which have different configurations depending on the NP coating (NPs attached to the liposome surface or encapsulated in its aqueous volume). The last system consists of two cell lines (Pan02 and Jurkat) incubated with the NPs. Dynamic magnetic behaviour (AC) was analysed in liquid samples, maintaining their colloidal properties, while quasi-static (DC) magnetic measurements were performed on lyophilised samples. AC measurements provide a direct method for determining the effect of the environment on the magnetization relaxation of nanoparticles. Thus, the imaginary (χ'') component shifts to lower frequencies as the aggregation state increases from free nanoparticles to those attached or embedded into liposomes in cell culture media and more pronounced when internalized by the cells. DC magnetization curves show no degradation of the NPs after interaction with biosystems in the analysed timescale. However, the blocking temperature is shifted to higher temperatures for the nanoparticles in contact with the cells, regardless of the location, the incubation time, the cell line and the nanoparticle coating, supporting AC susceptibility data. These results indicate that the simple fact of being in contact with the cells makes the nanoparticles aggregate in a non-controlled way, which is not the same kind of aggregation caused by the contact with the cell medium nor inside liposomes.

267 Spanish Exomes Reveal Population-Specific Differences in Disease-Related Genetic Variation.

Recent results from large-scale genomic projects suggest that allele frequencies, which are highly relevant for medical purposes, differ considerably across different populations. The need for a detailed catalog of local variability motivated the whole-exome sequencing of 267 unrelated individuals, representative of the healthy Spanish population. Like in other studies, a considerable number of rare variants were found (almost one-third of the described variants). There were also relevant differences in allelic frequencies in polymorphic variants, including ∼10,000 polymorphisms private to the Spanish population. The allelic frequencies of variants conferring susceptibility to complex diseases (including cancer, schizophrenia, Alzheimer disease, type 2 diabetes, and other pathologies) were overall similar to those of other populations. However, the trend is the opposite for variants linked to Mendelian and rare diseases (including several retinal degenerative dystrophies and cardiomyopathies) that show marked frequency differences between populations. Interestingly, a correspondence between differences in allelic frequencies and disease prevalence was found, highlighting the relevance of frequency differences in disease risk. These differences are also observed in variants that disrupt known drug binding sites, suggesting an important role for local variability in population-specific drug resistances or adverse effects. We have made the Spanish population variant server web page that contains population frequency information for the complete list of 170,888 variant positions we found publicly available (http://spv.babelomics.org/), We show that it if fundamental to determine population-specific variant frequencies to distinguish real disease associations from population-specific polymorphisms.

ngsCAT: a tool to assess the efficiency of targeted enrichment sequencing.

MOTIVATION: Targeted enrichment sequencing by next-generation sequencing is a common approach to interrogate specific loci or the whole exome in the human genome. The efficiency and the lack of bias in the enrichment process need to be assessed as a quality control step before performing downstream analysis of the sequence data. Tools that can report on the sensitivity, specificity, uniformity and other enrichment-specific features are needed. RESULTS: We have implemented the next-generation sequencing data Capture Assessment Tool (ngsCAT), a tool that takes the information of the mapped reads and the coordinates of the targeted regions as input files, and generates a report with metrics and figures that allows the evaluation of the efficiency of the enrichment process. The tool can also take as input the information of two samples allowing the comparison of two different experiments. AVAILABILITY AND IMPLEMENTATION: Documentation and downloads for ngsCAT can be found at http://www.bioinfomgp.org/ngscat.

Ecological functioning in grass-shrub Mediterranean ecosystems measured by eddy covariance.

Climate change may alter ecosystem functioning, as assessed via the net carbon (C) exchange (NEE) with the atmosphere, composed of the biological processes photosynthesis (GPP) and respiration (R(eco)). In addition, in semi-arid Mediterranean ecosystems, a significant fraction of respired CO2 is stored in the vadose zone and emitted afterwards by subsoil ventilation (VE), contributing also to NEE. Such conditions complicate the prediction of NEE for future change scenarios. To evaluate the possible effects of climate change on annual NEE and its underlying processes (GPP, R(eco) and VE) we present, over a climate/altitude range, the annual and interannual variability of NEE, GPP, R(eco) and VE in three Mediterranean sites. We found that annual NEE varied from a net source of around 130 gC m(-2) in hot and arid lowlands to a net sink of similar magnitude for alpine meadows (above 2,000 m a.s.l) that are less water stressed. Annual net C fixation increased because of increased GPP during intermittent and several growth periods occurring even during winter, as well as due to decreased VE. In terms of interannual variability, the studied subalpine site behaved as a neutral C sink (from emission of 49 to fixation of 30 gC m(-2) year(-1)), with precipitation as the main factor controlling annual GPP and R(eco). Finally, the importance of VE as 0-23% of annual NEE is highlighted, indicating that this process could shift some Mediterranean ecosystems from annual C sinks to sources.

Whole-exome sequencing identifies novel compound heterozygous mutations in USH2A in Spanish patients with autosomal recessive retinitis pigmentosa.

PURPOSE: Retinitis pigmentosa (RP) is an inherited retinal dystrophy characterized by extreme genetic and clinical heterogeneity. Thus, the diagnosis is not always easily performed due to phenotypic and genetic overlap. Current clinical practices have focused on the systematic evaluation of a set of known genes for each phenotype, but this approach may fail in patients with inaccurate diagnosis or infrequent genetic cause. In the present study, we investigated the genetic cause of autosomal recessive RP (arRP) in a Spanish family in which the causal mutation has not yet been identified with primer extension technology and resequencing. METHODS: We designed a whole-exome sequencing (WES)-based approach using NimbleGen SeqCap EZ Exome V3 sample preparation kit and the SOLiD 5500×l next-generation sequencing platform. We sequenced the exomes of both unaffected parents and two affected siblings. Exome analysis resulted in the identification of 43,204 variants in the index patient. All variants passing filter criteria were validated with Sanger sequencing to confirm familial segregation and absence in the control population. In silico prediction tools were used to determine mutational impact on protein function and the structure of the identified variants. RESULTS: Novel Usher syndrome type 2A (USH2A) compound heterozygous mutations, c.4325T>C (p.F1442S) and c.15188T>G (p.L5063R), located in exons 20 and 70, respectively, were identified as probable causative mutations for RP in this family. Family segregation of the variants showed the presence of both mutations in all affected members and in two siblings who were apparently asymptomatic at the time of family ascertainment. Clinical reassessment confirmed the diagnosis of RP in these patients. CONCLUSIONS: Using WES, we identified two heterozygous novel mutations in USH2A as the most likely disease-causing variants in a Spanish family diagnosed with arRP in which the cause of the disease had not yet been identified with commonly used techniques. Our data reinforce the clinical role of WES in the molecular diagnosis of highly heterogeneous genetic diseases where conventional genetic approaches have previously failed in achieving a proper diagnosis.

Late gadolinium enhancement-cardiovascular magnetic resonance identifies coronary artery disease as the aetiology of left ventricular dysfunction in acute new-onset congestive heart failure.

AIMS: We evaluated the ability of late gadolinium enhancement (LGE) using cardiovascular magnetic resonance (CMR) to identify acute new-onset heart failure (HF) with left ventricular systolic dysfunction (LVSD), whether or not in relation to underlying coronary artery disease (CAD), in patients with no clinical evidence of associated ischaemic cardiomyopathy. METHODS AND RESULTS: Hundred consecutive patients admitted with acute new-onset decompensated HF and EF <40%, with no clinical or electrocardiographic data suggestive of CAD. The patients were classified according to the presence or absence of significant CAD (stenosis > or =70% in at least one major vessel). Twenty-one patients (21%) had significant CAD. Seventy-nine (79%) had no lesions. Eighteen of the 21 patients (85%) with CAD had subendocardial/transmural LGE. In the diagnosis of CAD, LGE has a sensitivity of 85.7% (95% CI, 80-91) and specificity of 92.4% (95% CI, 87-96), respectively, with a negative predictive value of 96% (95% CI, 90-99). It has an area under the receiver operating characteristic curve of 0.906 (95% CI, 0.814-0.998). CONCLUSION: In patients with new-onset HF and LVSD for whom there are no clinical and exploratory data suggestive of ischaemic heart disease, CMR with LGE is an excellent means of ruling out significant CAD and is a valid alternative to angiography.

[Stent thrombosis in the modern era: incidence, outcome and predictive factors]. / Trombosis del stent en la era moderna: incidencia, consecuencias y factores predictores.

Coronary stent thrombosis is a catastrophic complication of percutaneous coronary intervention. Its incidence is reported to be about 1%, though it can occur more frequently in high-risk patients, in high-risk lesions, and in multivessel procedures. We investigated the occurrence of stent thrombosis in 404 consecutive patients in a period when conventional and drug-eluting stents were both being used. We found an overall incidence of 2.23%, a mortality rate of 22.2%, and a non-fatal myocardial infarction rate of 66.6%. Predictors of stent thrombosis were acute myocardial infarction, multiple stent placement, poor ejection fraction, small stent diameter, the presence of residual dissection, and premature discontinuation of clopidogrel.

Extension of human lncRNA transcripts by RACE coupled with long-read high-throughput sequencing (RACE-Seq).

Long non-coding RNAs (lncRNAs) constitute a large, yet mostly uncharacterized fraction of the mammalian transcriptome. Such characterization requires a comprehensive, high-quality annotation of their gene structure and boundaries, which is currently lacking. Here we describe RACE-Seq, an experimental workflow designed to address this based on RACE (rapid amplification of cDNA ends) and long-read RNA sequencing. We apply RACE-Seq to 398 human lncRNA genes in seven tissues, leading to the discovery of 2,556 on-target, novel transcripts. About 60% of the targeted loci are extended in either 5' or 3', often reaching genomic hallmarks of gene boundaries. Analysis of the novel transcripts suggests that lncRNAs are as long, have as many exons and undergo as much alternative splicing as protein-coding genes, contrary to current assumptions. Overall, we show that RACE-Seq is an effective tool to annotate an organism's deep transcriptome, and compares favourably to other targeted sequencing techniques.

[Anomalous left coronary artery from the right sinus of Valsalva associated with coronary atheromatosis]. / Arteria coronaria izquierda anómala en el seno de Valsalva derecho asociada a ateromatosis coronaria.

Anomalous origin of the left coronary artery from the right sinus of Valsalva is an anatomical abnormality that is usually associated with myocardial ischemia and sudden death. Although this abnormality may coexist with obstructive atherosclerotic coronary disease, disease is not usually found in the anomalous course of the artery. When this coronary anomaly and obstructive coronary disease are both present, it is difficult to determine the cause of ischemic symptoms. We report a case in which three different diagnostic techniques were used to find the cause of ischemic symptoms in a patient whose left coronary artery originated anomalously in the right sinus of Valsalva and followed a course between the aorta and the pulmonary trunk and who had obstructive atherosclerotic lesions in the right coronary artery. The techniques were conventional angiography, which was used for the initial diagnosis, multislice computerized tomography, which was used to determine the anomalous course of the artery and its relationship with vascular structures, and exercise echocardiography, which was used to evaluate ischemia in the left coronary artery territory after treatment of the stenoses in the right coronary artery.

[Prognostic value of persistent ST-segment elevation after successful primary angioplasty]. / Valor pronóstico de la persistencia del segmento ST elevado después de una angioplastia primaria realizada con éxito.

INTRODUCTION AND OBJECTIVES: A variable percentage of patients with myocardial infarction treated with successful primary angioplasty and restoration of coronary flow show persistent ST-segment elevation, probably due to inadequate cellular reperfusion. We studied if persistent ST-segment elevation was a predictor of worse prognosis. PATIENTS AND METHODS: We comparatively studied the clinical and angiographic results of 116 acute myocardial infarction patients after successful primary angioplasty, which were classified into two groups depending on the persistence (> 50%) or reduction (

Radioterapia en colgajos peroneos. Revisión de la densidad ósea y complicaciones en colgajos peroneos irradiados frente a no irradiados / Effects of radiotherapy in fibular free flaps. Study of bone density and complications in irradiated fibular flaps vs no irradiated

INTRODUCCIÓN: El colgajo peroneo es actualmente una de las técnicas más elegidas para la reconstrucción de defectos mandibulares. Muchos de los pacientes reconstruidos con este colgajo presentan patología oncológica que precisa tratamiento adyuvante con radioterapia. Los efectos adversos de la radioterapia sobre los tejidos son conocidos, pudiendo desembocar en osteoradionecrosis. El objetivo de este estudio es el análisis de la densidad ósea de los colgajos peroneos en los pacientes que han recibido radioterapia frente a los que no y su posible correlación con las complicaciones posteriores. MATERIAL Y MÉTODOS: Realizamos un estudio retrospectivo de los colgajos peroneos realizados por nuestro servicio desde enero 2011 hasta diciembre 2016. Los criterios de inclusión de los pacientes fue el haber sido reconstruidos con un colgajo peroneo y disponer de un TC de control a los tres meses postradioterapia en caso de haberla precisado. Se recogió la edad, densidad ósea peronea, desviación estándar cuerpo mandibular remanente y colgajo peroneo, así como las complicaciones postoperatorias. Los datos extraídos fueron analizados a través del Software SAS (Statistical Analisys System). RESULTADOS: En total se recogieron 61 pacientes, siendo la media de edad de 54,46 años. De estos 61 pacientes se excluyeron 11 al no presentar TC de control; de los 50 pacientes restantes, 27 recibieron tratamiento radioterápico adyuvante (54 %), mientras que 23 no la recibieron (46 %). En los pacientes irradiados, un alto porcentaje (84,62 %) recibieron altas dosis de radioterapia (> 60 Gy). Se encontraron diferencias estadísticamente significativas (p < 0,05) respecto a la edad y la desviación estándar de la densidad ósea del cuerpo mandibular remanente, mientras que en el resto de los parámetros no se encontraron diferencias estadísticamente significativas. Los pacientes irradiados presentaron un mayor porcentaje de complicaciones frente a los pacientes no irradiados, sin diferencias estadísticamente significativas. Discusión: Las nuevas técnicas de radioterapia de intensidad modulada permiten una dosis relativamente uniforme en un objetivo, evitando altas dosis en los tejidos circuncidantes. A pesar del avance en las técnicas de radioterapia, actualmente en la mayoría de centros se continúa realizando un tratamiento completo del volumen del lecho tumoral, que incluye en el campo de irradiación el colgajo con el que se reconstruye. Los casos de osteonecrosis mandibular que se presentaron fueron en pacientes irradiados y a nivel del cuerpo mandibular remanente. La densidad ósea a nivel del colgajo peroneo sí que presentó diferencias estadísticamente significativas en pacientes irradiados frente a no irradiados; este aspecto puede influir en el índice de complicaciones. CONCLUSIONES: Consideramos, con los resultados del estudio, plantear nuevos estudios prospectivos para valorar la necesidad de irradiar el tejido óseo del colgajo peroneo como parte del volumen del lecho tumoral, siendo que este tejido no ha estado en contacto con el tumor primario, ante el mayor índice de complicaciones asociados a la radioterapia en estos tejidos

INTRODUCTION: The fibular flap is currently one of the most chosen techniques for the reconstruction of mandibular defects. Many of the patients reconstructed with this flap present oncological pathology that requires adjuvant treatment with radiotherapy. The adverse effects of radiotherapy on tissues are known, and can lead to osteoradionecrosis. The aim of this study is to analyze the bone density of peroneal flaps in patients who have received radiotherapy against those who do not and their possible correlation with subsequent complications. MATERIAL AND METHODS: We designed a retrospective study of the fibular flaps performed by our service from January 2011 to December 2016. The criteria for inclusion of patients was to have been reconstructed with a peroneal flap and have a control CT at 3 months after radiotherapy. Age, bone density, standard deviation and further complications were extracted. The extracted data was analyzed through the SAS (statistical Analisys System) Software. RESULTS: 61 patients were collected; the mean age was of 54.46 years. Of these 61 patients were excluded 11 by not presenting control TC, of the 50 patients remaining, 27 received adjuvant radiotherapy treatment (54 %) while 23 did not receive (46 %). In irradiated patients a high percentage (84.62 %) received high doses of radiotherapy (> 60 Gy). Statistically significant differences were found (P < 0.05) with respect to age and standard deviation of bone density of the remaining mandibular body, while in the rest of the parameters no statistical significant differences were found. Irradiated patients presented a higher percentage of complications compared to non-irradiated patients without statistically significant differences. Discussion: The new techniques of intensity-modulated radiotherapy allow a relatively uniform dose in a target, avoiding high doses in the circumcising tissues. Despite the progress in radiotherapy techniques, currently in most centers, it continues to perform a complete treatment of the volume of the tumor bed that includes in the field of irradiation the flap with which it is reconstructed. The cases of mandibular osteonecrosis that were presented were in irradiated patients and in the remaining mandible. Bone density at the level of the fibular flap showed statistically significant differences in irradiated patients compared to non-irradiated, this aspect may influence in the index of complications. CONCLUSIONS: We consider to propose new prospective studies to assess the need to irradiate the bone tissue of the fibular flap as part of the volume of the tumor bed, knowing that this tissue has not been in contact with the primary tumor, and the high index of complications associated with radiotherapy

Radioterapia en colgajos peroneos. Revisión de la densidad ósea en colgajos peroneos irradiados frente a no irradiados / Radiotherapy in fibular flaps. Review of bone density and complications after radiotherapy

INTRODUCCIÓN: El colgajo peroneo es actualmente una de las técnicas más elegidas para la reconstrucción de defectos mandibulares. Muchos de los pacientes reconstruidos con este colgajo presentan patología oncológica que precisa tratamiento adyuvante con radioterapia. Los efectos adversos de la radioterapia sobre los tejidos son conocidos, pudiendo desembocar en osteorradionecrosis. El objetivo de este estudio es el análisis de la densidad ósea de los colgajos peroneos en los pacientes que han recibido radioterapia frente a los que no, y su posible correlación con las complicaciones posteriores. MATERIAL Y MÉTODOS: Realizamos un estudio retrospectivo de los colgajos peroneos realizados por nuestro servicio desde enero de 2011 hasta diciembre de 2016. Los criterios de inclusión de los pacientes fue el haber sido reconstruidos con un colgajo peroneo y disponer de un TC de control a los tres meses postradioterapia en caso de haberla precisado. Se recogió la edad, densidad ósea peronea, desviación estándar cuerpo mandibular remanente y colgajo peroneo, así como las complicaciones postoperatorias. Los datos extraídos fueron analizados a través del Software SAS (Statistical Analisys System). RESULTADOS: En total se recogieron 61 pacientes, siendo la media de edad de 54,46 años. De estos 61 pacientes se excluyeron 11 al no presentar TC de control, de los 50 pacientes restantes, 27 recibieron tratamiento radioterápico adyuvante (54 %) mientras 23 no la recibieron (46 %). En los pacientes irradiados un alto porcentaje (84,62 %) recibieron altas dosis de radioterapia (> 60 Gy). Se encontraron diferencias estadísticamente significativas (p < 0,05) respecto a la edad y la desviación estándar de la densidad ósea del cuerpo mandibular remanente, mientras que en el resto de los parámetros no se encontraron diferencias estadísticamente significativas. Los pacientes irradiados presentaron un mayor porcentaje de complicaciones frente a los pacientes no irradiados sin diferencias estadísticamente significativas. DISCUSIÓN Las nuevas técnicas de radioterapia de intensidad modulada permiten una dosis relativamente uniforme en un objetivo, evitando altas dosis en los tejidos circuncidantes. A pesar del avance en las técnicas de radioterapia, actualmente en la mayoría de centros se continúa realizando un tratamiento completo del volumen del lecho tumoral, que incluye en el campo de irradiación el colgajo con el que se reconstruye. Los casos de osteonecrosis mandibular que se presentaron fueron en pacientes irradiados y a nivel del cuerpo mandibular remanente. La densidad ósea a nivel del colgajo peroneo sí que presentó diferencias estadísticamente significativas en pacientes irradiados frente a no irradiados; este aspecto puede influir en el índice de complicaciones. CONCLUSIONES: Consideramos con los resultados del estudio, plantear nuevos estudios prospectivos para valorar la necesidad de irradiar el tejido óseo del colgajo peroneo como parte del volumen del lecho tumoral, siendo que este tejido no ha estado en contacto con el tumor primario, ante el mayor índice de complicaciones asociados a la radioterapia en estos tejidos

INTRODUCTION: The fibular flap is currently one of the most chosen techniques for the reconstruction of mandibular defects. Many of the patients reconstructed with this flap present oncological pathology that requires adjuvant treatment with radiotherapy. The adverse effects of radiotherapy on tissues are known, and can lead to Osteorradionecrosis. The aim of this study is to analyze the bone density of peroneal flaps in patients who have received radiotherapy against those who do not and their possible correlation with subsequent complications. MATERIAL AND METHODS: We designed a retrospective study of the fibular flaps performed by our service from January 2011 to December 2016. The criteria for inclusion of patients was to have been reconstructed with a peroneal flap and have a control CT at 3 months after radiotherapy. Age, bone density, standard deviation and further complications were extracted. The extracted data was analyzed through the SAS (statistical Analisys System) Software. RESULTS: 61 patients were collected; the mean age was of 54.46 years. Of these 61 patients were excluded 11 by not presenting control TC, of the 50 patients remaining, 27 received adjuvant radiotherapy treatment (54 %) while 23 did not receive (46 %). In irradiated patients a high percentage (84.62 %) received high doses of radiotherapy (> 60 Gy). Statistically significant differences were found (p < 0.05) with respect to age and standard deviation of bone density of the remaining mandibular body, while in the rest of the parameters no statistical significant differences were found. Irradiated patients presented a higher percentage of complications compared to non-irradiated patients without statistically significant differences. DISCUSSION: The new techniques of intensity-modulated radiotherapy allow a relatively uniform dose in a target, avoiding high doses in the circumcising tissues. Despite the progress in radiotherapy techniques, currently in most centers, it continues to perform a complete treatment of the volume of the tumor bed that includes in the field of irradiation the flap with which it is reconstructed. The cases of mandibular osteonecrosis that were presented were in irradiated patients and in the remaining mandible. Bone density at the level of the fibular flap showed statistically significant differences in irradiated patients compared to non-irradiated, this aspect may influence in the index of complications. CONCLUSIONS: We consider to propose new prospective studies to assess the need to irradiate the bone tissue of the fibular flap as part of the volume of the tumor bed, knowing that this tissue has not been in contact with the primary tumor, and the high index of complications associated with radiotherapy

A randomized study to compare bioactive titanium stents and everolimus-eluting stents in diabetic patients (TITANIC XV): 1-year results.

INTRODUCTION AND OBJECTIVES: Up to 25% of patients who undergo a percutaneous coronary intervention show some limitation in the use of drug-eluting stents. The aim of this study was to evaluate if titanium-nitride-oxide-coated stents could be a good alternative to everolimus-eluting stents in diabetic patients. METHODS: A total of 173 diabetic patients with lesions at moderate risk of restenosis (exclusion criteria: diameter < 2.5 mm or length > 28 mm in vessels < 3mm, chronic occlusion) were randomized to a titanium group (83 patients) or an everolimus group (90 patients). RESULTS: Baseline characteristics were well balanced; 28.3% of patients were insulin dependent. At 1 year, the incidence of major adverse cardiac events (death, nonfatal myocardial infarction, stroke, or repeat target vessel revascularization) was significantly higher in the titanium group than in the everolimus group (total, 14.5% vs 4.4%; P = .02; noninsulin-dependent subgroup, 9.7% vs 3.2%; P = .14; insulin-dependent subgroup, 28.6% vs 7.1%; P = .04). The incidence of death, nonfatal myocardial infarction, stroke, or any revascularization was 16.9% in the titanium group and 7.8% in the everolimus group (P = .06). Target lesion and vessel revascularizations occurred in 8.4% compared with 3.3% (P = .15) and in 13.3% compared with 3.3% (P = .01) in the titanium and everolimus groups, respectively. Angiographic follow-up at 9 months showed significantly less late lumen loss in the everolimus group (in-segment, 0.52 [standard deviation, 0.58) mm vs -0.05 [0.32] mm; in-stent, 0.76 [0.54] mm vs 0.13 [0.31] mm; P < .0001). CONCLUSIONS: The everolimus-eluting stent is superior to the titanium stent for clinical and angiographic end points in diabetic patients with lesions at moderate risk of restenosis.

Carcinoma análogo secretor de mama: revisión de diagnóstico y tratamiento a propósito de 2 casos / Mammary analogue secretory carcinoma: presentation of 2 cases and a review of its diagnosis and treatment

Introducción. El carcinoma análogo secretor de mama (MASC: mammary analogue secretory carcinoma) es una entidad neoplásica de las glándulas salivares caracterizada por presentar importantes similitudes histológicas e inmunohistoquímicas con el carcinoma secretor de mama. Hasta su descripción en 2010, el MASC era frecuentemente clasificado como carcinoma de células acinares por su solapamiento morfológico. Ante la falta de evidencia científica en la literatura respecto al tratamiento óptimo de estos tumores, el objetivo de este artículo es presentar 2casos tratados recientemente en nuestro servicio y revisar la literatura descrita acerca de su diagnóstico y tratamiento. Material y métodos. Se trata de un paciente varón de 41 años con diagnóstico de MASC de glándula salivar menor en paladar duro y de una paciente de 56 años con el mismo diagnóstico en la glándula submaxilar. Resultados. En ambos casos se realizó resección quirúrgica con márgenes de la lesión. En uno de ellos, al presentar bordes libres, se decidió control clínico, mientras que en el otro se decidió tratamiento adyuvante con radioterapia al presentar un borde cercano a la lesión. Ambos pacientes tras 2años están libres de enfermedad y mantienen seguimiento clínico. Discusión. En la literatura se había descrito la existencia de un tumor de glándulas salivares con unas características morfológicas comunes entre el carcinoma de células acinares y el carcinoma secretor de mama, caracterizado inmunohistoquímicamente por ser positivo a vimentina y a la proteína S-100, pero no fue conocido como MASC hasta su descripción en 2010. La alteración genética asociada al MASC es la presencia de la translocación t(12;15)(p13;q25) en el oncogén ETV6-NTRK3, lo que lo convierte en un marcador prácticamente patognomónico de este tumor. Respecto al tratamiento, existe consenso en el tratamiento quirúrgico de la lesión primario, y no existe consenso respecto a la disección cervical. El valor de la RT postoperatoria es difícilmente valorable por los escasos casos en la literatura. Conclusiones. El MASC es una enfermedad neoplásica de glándula salivar que precisa un diagnóstico correcto previo a la elección de su tratamiento. Debido a su comportamiento como una neoplasia maligna de bajo grado, consideramos que su tratamiento debe ser el quirúrgico, con unos márgenes de seguridad a la lesión, pero en algunos casos su comportamiento puede ser agresivo (AU)

Introduction. Mammary analogue secretory carcinoma (MASC) is a neoplastic tumour of the salivary glands, characterised by having important histological and immuno-histochemical similarities with secretory breast carcinoma. Until its description in 2010, MASC was often diagnosed as carcinoma of acinar cells due to their morphological overlapping. As there is a lack of evidence in the scientific literature concerning the optimal treatment of these tumours, the aim of this article is to present 2recently treated cases, and review the described literature about their diagnosis and treatment. Material and methods. The first case concerns a 41 year-old male with MASC of the minor salivary gland of the hard palate, and the other a 56 year-old patient with the same diagnosis at the level of the submandibular gland. Results. Surgical resection with lesion-free margins was performed in both cases. Clinical surveillance was decided for one case with free margins, while in the other one, it was decided to give adjuvant therapy with radiotherapy due to the narrow lesion free margin. Both patients are disease free and continue on clinical follow-up. Discussion. The literature describes the existence of a salivary glands tumour with common morphological characteristics between acinar cell carcinoma and breast carcinoma, and immunohistochemically characterised by being positive to vimentin and S-100 protein, but it was not known as MASC until its description in 2010. The genetic alteration associated with MASC is the presence of a translocation t(12;15) (q25; Q13) in ETV6-NTRK3, making it a pathognomonic tumour marker. There is consensus in the surgical treatment of primary lesions, but there is no agreement as regards neck dissection. The value of post-surgical radiotherapy is difficult to assess by the few cases in the literature. Conclusions. MASC is a recently described salivary gland tumour characterised by ETV6 translocation. Due to its behaviour as a low grade malignant neoplasm, it is recommended that its treatment should be excision with surgical margins, but in some cases its behaviour can be aggressive (AU)

Trombosis aórtica como causa de infarto de miocardio en paciente joven / Aortic thrombosis, a rare cause of acute myocardial infarction in young patients

No disponible

Estudio aleatorizado para comparar el stentbioactivo de titanio con el stent de everolimus en pacientes diabéticos (TITANIC XV), resultados a 1 año / A Randomized Study to Compare Bioactive Titanium Stents and Everolimus-eluting Stents in Diabetic Patients (TITANIC XV): 1-year Results

Introducción y objetivos Hasta un 25% de los pacientes sometidos a intervencionismo coronario percutáneo presentan alguna limitación para la utilización de los stents farmacoactivos. Nuestro objetivo es evaluar si el stent bioactivo de titanio y óxido nítrico podía ser una buena alternativa al stent de everolimus para pacientes diabéticos.MétodosSe aleatorizó a 173 pacientes diabéticos con lesiones de riesgo de reestenosis intermedio (criterios de exclusión: diámetro < 2,5 mm o longitud > 28 mm en vasos < 3 mm, oclusión crónica): 83 pacientes en el grupo con titanio y 90 en el grupo con everolimus.ResultadosLas variables basales estaban bien equilibradas, el 28,3% eran insulinodependientes. Al año, las incidencias de eventos adversos cardiacos mayores (muerte, infarto de miocardio no fatal, ictus o nueva revascularización del vaso tratado) eran significativamente más frecuente en el grupo con titanio que en el grupo con everolimus (total, el 14,5 frente al 4,4%; p = 0,02; subgrupo no insulinodependiente, el 9,7 frente al 3,2%; p = 0,14; insulinodependiente, el 28,6 frente al 7,1%; p = 0,04) y de muerte, infarto de miocardio no fatal, ictus o cualquier revascularización, del 16,9% en el grupo con titanio y el 7,8% en el grupo con everolimus (p = 0,06). La revascularización de la lesión diana se produjo en el 8,4 frente al 3,3% (p = 0,15), y la del vaso tratado, el 13,3 frente al 3,3% (p = 0,01). El seguimiento angiográfico a 9 meses mostró una pérdida luminal tardía significativamente menor en el grupo con everolimus (en el segmento, 0,52 ± 0,58 frente a -0,05 ± 0,32 mm; en el stent, 0,76 ± 0,54 frente a 0,13 ± 0,31 mm; p < 0,0001). ConclusionesEl stent de everolimus fue superior al titanio en pacientes diabéticos incluso con lesiones de riesgo de eventos clínicos y angiográficos intermedio (AU)

Introduction and objectives Up to 25% of patients who undergo a percutaneous coronary intervention show some limitation in the use of drug-eluting stents. The aim of this study was to evaluate if titanium-nitride-oxide-coated stents could be a good alternative to everolimus-eluting stents in diabetic patients.MethodsA total of 173 diabetic patients with lesions at moderate risk of restenosis (exclusion criteria: diameter < 2.5 mm or length > 28 mm in vessels < 3 mm, chronic occlusion) were randomized to a titanium group (83 patients) or an everolimus group (90 patients).ResultsBaseline characteristics were well balanced; 28.3% of patients were insulin dependent. At 1 year, the incidence of major adverse cardiac events (death, nonfatal myocardial infarction, stroke, or repeat target vessel revascularization) was significantly higher in the titanium group than in the everolimus group (total, 14.5% vs 4.4%; P = .02; noninsulin-dependent subgroup, 9.7% vs 3.2%; P = .14; insulin-dependent subgroup, 28.6% vs 7.1%; P = .04). The incidence of death, nonfatal myocardial infarction, stroke, or any revascularization was 16.9% in the titanium group and 7.8% in the everolimus group (P = .06). Target lesion and vessel revascularizations occurred in 8.4% compared with 3.3% (P = .15) and in 13.3% compared with 3.3% (P = .01) in the titanium and everolimus groups, respectively. Angiographic follow-up at 9 months showed significantly less late lumen loss in the everolimus group (in-segment, 0.52 [standard deviation, 0.58) mm vs -0.05 [0.32] mm; in-stent, 0.76 [0.54] mm vs 0.13 [0.31] mm; P < .0001).ConclusionsThe everolimus-eluting stent is superior to the titanium stent for clinical and angiographic end points in diabetic patients with lesions at moderate risk of restenosis (AU)

[Long-term clinical and angiographic follow-up of drug-eluting stents in patients with ST-elevation acute myocardial infarction]. / Resultados clínicos y angiográficos tardíos de stents liberadores de fármacos en pacientes con infarto agudo de miocardio con elevación del ST.

INTRODUCTION AND OBJECTIVES: Drug-eluting stents (DES) have proven to be effective in reducing the rate of restenosis and have, therefore, been incorporated into the treatment of patients with ST-elevation acute myocardial infarction (STEMI). The aim of this study was to investigate long-term clinical and angiographic outcomes following the use of DESs in patients with STEMI. METHODS: A prospective study involving clinical and angiographic follow-up was performed in 81 patients with STEMI who underwent percutaneous coronary intervention including DES implantation. This group was compared with 82 patients with similar characteristics who were treated with bare-metal stents (BMS) in an earlier period. RESULTS: At one year, there was no significant difference between the groups in the mortality (2.5% in the DES group vs 7.3% in the BMS group; P=.15) or reinfarction rate (4.8% in the DES group vs. 4.8% in the BMS group; P=.98). The target lesion revascularization rate was significantly lower in the DES group (8.6% vs 23.2% in the BMS group; P=.001), as was the restenosis rate (13.8% vs. 30.9% in the BMS group; P=.02). Acute or subacute stent thrombosis was diagnosed in five patients (3 with a DES and 2 with a BMS; P=.64), and one late stent thrombosis was detected after a year, in a sirolimus-eluting stent. CONCLUSIONS: Implantation of a DES in patients with STEMI did not result in a reduction in either the mortality or reinfarction rate at 1 year compared with BMS implantation. However, there were reductions in the rates of restenosis and target lesion revascularization. The incidence of thrombosis was similar with the two types of stent.

Resultados clínicos y angiográficos tardíos de stents liberadores de fármacos en pacientes con infarto agudo de miocardio con elevación del ST / Long-term clinical and angiographic follow-up of drug-eluting stents in patients with ST-elevation acute myocardial infarction

Introducción y objetivos. Los stents liberadores de fármacos (SLF) han demostrado reducir la reestenosis y por ello se han incorporado al tratamiento de pacientes con infarto agudo de miocardio con elevación del ST (IAMEST). En este trabajo se han evaluado los resultados clínicos y angiográficos a largo plazo de los SLF en pacientes con IAMEST. Métodos. Se realizó prospectivamente un seguimiento clínico y angiográfico de 81 pacientes con IAMEST sometidos a intervencionismo coronario percutáneo con implante de SLF. Este grupo se comparó con otro de 82 pacientes con características similares, tratados con stents convencionales (SC) en un período anterior. Resultados. Al año no hubo diferencias significativas en las tasas de mortalidad (2,5% en el grupo SLF y 7,3% en el grupo SC; p = 0,15) o reinfarto (4,8% del grupo SLF y 4,8% del grupo SC; p = 0,98). La necesidad de nueva revascularización de la lesión fue menor en el grupo SLF (8,6 y 23,2%; p = 0,001) al igual que la tasa de reestenosis (13,8% del grupo SLF y 30,9% del grupo SC; p = 0,02). Se registraron 5 trombosis agudas o subagudas de stent (3 SLF y 2 SC; p = 0,64) y una tardía después del año en un stent de sirolimus. Conclusiones. El implante de SLF en pacientes con IAMEST no reduce la mortalidad o el reinfarto al año respecto a los SC; sin embargo, reduce la tasa de reestenosis y la necesidad de nueva revascularización. La incidencia de trombosis de stent fue similar en los dos grupos

Introduction and objectives. Drug-eluting stents (DES) have proven to be effective in reducing the rate of restenosis and have, therefore, been incorporated into the treatment of patients with ST-elevation acute myocardial infarction (STEMI). The aim of this study was to investigate long-term clinical and angiographic outcomes following the use of DESs in patients with STEMI. Methods. A prospective study involving clinical and angiographic follow-up was performed in 81 patients with STEMI who underwent percutaneous coronary intervention including DES implantation. This group was compared with 82 patients with similar characteristics who were treated with bare-metal stents (BMS) in an earlier period. Results. At one year, there was no significant difference between the groups in the mortality (2.5% in the DES group vs 7.3% in the BMS group; P=.15) or reinfarction rate (4.8% in the DES group vs. 4.8% in the BMS group; P=.98). The target lesion revascularization rate was significantly lower in the DES group (8.6% vs 23.2% in the BMS group; P=.001), as was the restenosis rate (13.8% vs. 30.9% in the BMS group; P=.02). Acute or subacute stent thrombosis was diagnosed in five patients (3 with a DES and 2 with a BMS; P=.64), and one late stent thrombosis was detected after a year, in a sirolimus-eluting stent. Conclusions. Implantation of a DES in patients with STEMI did not result in a reduction in either the mortality or reinfarction rate at 1 year compared with BMS implantation. However, there were reductions in the rates of restenosis and target lesion revascularization. The incidence of thrombosis was similar with the two types of stent